Comparative evaluation of the sensitivity of acinetobacter to colistin, using the prediffusion and minimum inhibitory concentration methods. detection of heteroresistant isolates;Sensibilidad de acinetobacter a la colistina evaluada mediante los métodos de predifusión y de concentración inhibitoria mínima. detección de aislamientos heterorresistentes

Revista Argentina de Microbiologia

Volumn 43, Issue 2, 2011, Pages 115-119

  Herrera, Melina E ^a   Mobilia, Liliana N ^a,b   Posse, Graciela R ^a,c  

^a Universidad Adventista del Plata   (Argentina)

^b Laboratorio Domingo I Nanni   (Argentina)

^c Laboratorio de Bacteriología Sanatorio Adventista del Plata ^*  (Argentina)

Author keywords

Acinetobacter; Colistin; Heteroresistance; Prediffusion

Indexed keywords

COLISTIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; DIFFUSION; DISPERSION; EVALUATION; LINEAR REGRESSION ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SENSITIVITY ANALYSIS;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ACINETOBACTER INFECTIONS; ARGENTINA; COLISTIN; DIFFUSION; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; LINEAR MODELS; MICROBIAL SENSITIVITY TESTS;

EID: 79959680965     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epi-demiological features. Clin Microbiol Rev 1996; 9: 148-165.
2. Borda N, Mari R, Tome G, Cocconi E, Morettin A, Limansky A, Cera G, Notario R, Fay F, Casellas JM, Bou Casals J. Comparación de los métodos de difusión, predifusión y epsilométrico en aislados de Acinetobacter baumannii-calcoaceticus complex frente a colistina. IV Actividad Científca Anual de la Sociedad Argentina de Bacteriolo-gía Clínica. Encuentro SADI-SADEBAC, 2006, Resumen 16431, p. 82, Buenos Aires, Argentina.
3. Bou G, Cerveró G, Domínguez MA, Querada C, Martínez-Beltrán J. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hidrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of b-lactamases. J Clin Microbiol 2000; 38: 3205-3299.
4. Cisneros-Herreros JM, Garnacho-Montero J, Pachón-Ibañez ME. Nosocomial pneumonia due to Acinetobacter baumannii. Enferm Infecc Microbiol Clin 2005; 23 suppl 3: 46-51.
5. Clinical and Laboratory Standard Institute. Performance Standards for Antimicrobial Susceptibility Testing, 15th informational supplement, 2008; M100-S18 Vol. 28 N° 1: 45-46. Wayne, PA, EE.UU.
6. Del Mar Tomas M, Cartelle M, Pertega S, Beceiro A, Llina-res P, Canle D, Molina F, Villanueva R, Cisneros JM, Bou G. Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonization and infection. Clin Microbiol Infect 2005; 11: 540-546.
7. Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 2005; 40: 1333-1341.
8. Galani I, Kontopidou F, Souli M, Rekatsina PD, Koratzanis E, Deliolanis J, Giamarellou H. Colistin susceptibility testing by Etest and disk diffusion methods. Int J Antimicrob Agents 2008; 31: 434-439.
9. Gales AC, Reis AO, Jones RN. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol 2001; 39: 183-190.
10. Garnacho-Montero J, Ortiz-Leyba C, Jiménez-Jiménez FJ, Barrero-Almodóvar AE, García-Garmendia JL, Bernabeu-Wittell M, Gallego-Lara SL, Madrazo-Osuna J. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis 2003; 36: 1111-1118.
11. Gounden R, Bamford C, van Zyl-smit R, Cohen K, Maartens G. Safety and effectiveness of colistin compared with to-bramycin for multi-drug resistant Acinetobacter baumannii infections. BMC Infect Dis 2009; 9:26.
12. Hawley JS, Murray CK, Jorgensen JH. Colistin heterore-sistance in Acinetobacter baumannii with previous colistin therapy. Antimicrob Agents Chemother 2008; 52: 351-352.
13. Landman D, Georgescu C, Martin DA, Quale J. Polymyxins revisited. Clin Microbiol Rev 2008; 21: 449-465.
14. Levin AS, Barone AA, Penco J, Santos MV, Marinho IS, Arruda EAG, Manrique EI, Costa SF. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 2002; 35: 901-902.
15. Li J, Rayner CR, Nation RL, Owen RJ, Spelman D, Tan KE, Liolios L. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2006; 50: 2946-2950.
16. Lo-Ten Foe JR, de Smet AMGA, Diederen BMW, Kluytmans JAJW, van Keulen PHJ. Comparative evaluation of the VITEK 2, disk diffusion, Etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains. Antimicrob Agents Chemother 2007; 51: 3726-3730.
17. Mukhopadhyay C, Krishna S, Vandana KE, Shenoy S, Bairy I. Ventilator-associated pneumonia with col-s strains: a successful comeback of colistin! Braz J Infect Dis 2008; 12: 444-446.
18. th Eur Cong Microbiol Inf Dis (ECCMID) 2005.
19. Rodríguez CH, Pautaso J, Bombicino K, Vay C, Famiglietti A. Sensibilidad a colistín: evaluación de los puntos de corte disponibles en el antibiograma por difusión. Rev Argent Microbiol 2004; 36: 125-129.
20. Schell C, Posse G, Mobilia L, Limansky A, Bantar C. Comparative time-kill study of doxycycline, tigecycline, sulbactam, and imipenem against several clones of Acinetobacter baumannii. Diagn Microbiol Infect Dis 2008; 61: 309-314.
21. th edition. Washington D.C., ASM Press, 2007, p.371-376.
22. th edition. Baltimore, 1996, p 418-431.
23. Sistema informático de Resistencia. http://www.aam.org.ar/
24. Tan CH, Li J, Nation RL. Activity of colistin against hete-roresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic/pharmacodynamic model. Antimicrob Agents Chemother 2007; 51: 3413-3415.
25. th Ed, 2007-2008, p 18.
26. Vila J, Pachón J. Therapeutic options for Acinetobacter baumanii infections. Expert Opin Pharmacother 2008; 9: 587-599.
27. Wroblewska MM, Towner KJ, Marchel H, Luczak M. Emergence and spread of carbapenem-resistant strains of Acinetobacter baumannii in a tertiary-care hospital in Poland. Clin Microbiol Infect 2007; 13: 490-496.